Literature DB >> 15093686

Human angiotensin II type-2 receptor inhibition of insulin-mediated ERK-2 activity via a G-protein coupled signaling pathway.

Steven A Moore1, Nancy Huang, Olivia Hinthong, Robert D Andres, Tom N Grammatopoulos, James A Weyhenmeyer.   

Abstract

While it has been shown that the angiotensin type-2 (AT(2)) receptor plays an important role in the development and differentiation of many tissues, the second messengers involved in its signaling pathways are just beginning to be understood. To further determine the signaling pathways for the AT(2) receptor, we have investigated whether human angiotensin type-2 receptor transfected into Chinese hamster ovary (CHO) cells can modulate insulin-induced extracellular signal-related protein kinase (ERK-2) phosphorylation via a G-protein coupled mechanism. Our results indicate that the human AT(2) receptor decreases insulin-induced ERK-2 phosphorylation through a G-protein mediated pathway since inhibition was attenuated by pertussis toxin (a G(i)/G(0) inhibitor). Our findings further indicate that the inhibitory response was insensitive to sodium orthovanadate (a PTPase inhibitor), but sensitive (attenuated) to okadaic acid, suggesting an important role for protein phosphatase 2A (PP2A). We have also shown that alanine substitution of the putative G-protein coupling DRY(141-143) motif of the second intracellular loop significantly decreases the human AT(2) receptor's ability to inhibit insulin-induced ERK-2 phosphorylation. Our results support the hypothesis that the AT(2) receptor inhibits insulin-induced ERK-2 activity via a G-protein coupled pathway involving the up-regulation of PP2A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093686     DOI: 10.1016/j.molbrainres.2004.02.006

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  5 in total

Review 1.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

2.  Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study.

Authors:  Xiaoliang Cong; Xiaogang Zhang; Xin Liang; Xinheng He; Yehua Tang; Xing Zheng; Shaoyong Lu; Jiayou Zhang; Ting Chen
Journal:  Comput Struct Biotechnol J       Date:  2022-05-10       Impact factor: 6.155

3.  A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

4.  Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen.

Authors:  Yoot Mo Lee; Min Jae Seong; Jae Woong Lee; Yong Kyung Lee; Tae Myoung Kim; Sang Yoon Nam; Dae Joong Kim; Young Won Yun; Tae Seong Kim; Soon Young Han; Jin Tae Hong
Journal:  J Vet Sci       Date:  2007-03       Impact factor: 1.672

5.  Distinct effects of contraction agonists on the phosphorylation state of cofilin in pulmonary artery smooth muscle.

Authors:  Yan-Ping Dai; Shaner Bongalon; Violeta N Mutafova-Yambolieva; Ilia A Yamboliev
Journal:  Adv Pharmacol Sci       Date:  2007-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.